未找到相关数据
Trouble at the office
被引：3
作者：
Allison, Malorye
机构：
[1] Acton,
[2] Massachusetts ,undefined
关键词：
D O I：
10.1038/nbt0908-967
中图分类号：
Q81 [生物工程学（生物技术）];
Q93 [微生物学];
学科分类号：
071005 ;
0836 ;
090102 ;
100705 ;
摘要：
The FDA's Office of Oncology Products has come in for stinging criticism from drug developers, advocates and even a US legislator over the use of surrogate endpoints. Has the agency struck the right balance between speed and caution? Malorye Allison investigates.
引用
收藏
页码：967 / 969
页数：3
相关论文